March 6, 2025 – The Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program leverages the combined, complementary capital, expertise and resources of OBIO® and FACIT. The resulting synergies provide a continuum of seamless support and lower barriers faced by women STEM leaders in accessing business training, advisory resources, networks and venture funding.
Category: Announcement
RSVP for Falcons’ Fortunes Pitch Finals on March 20, 2025
February 4, 2025 – The annual Falcons’ Fortunes event, hosted by FACIT, features six Ontario entrepreneurs vying for the $100,000 award in the province’s only pitch competition specifically promoting cancer breakthroughs.
Now in its 12th year, Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community. FACIT is cultivating entrepreneurial scientists who will drive a culture of commercialization where Ontario-based cancer research becomes Ontario-made solutions to benefit patients worldwide.
Read More from RSVP for Falcons’ Fortunes Pitch Finals on March 20, 2025
Idea to Investment Podcast: How FACIT’s support propels early cancer innovations
January 17, 2025 – FACIT’s David Koehler, Director of Fund Operations, appeared on TechAlliance’s Idea to Investment podcast along with Saumik Biswas, President, CEO and Founder of Tenomix Inc. based in London, Ontario. Tenomix’s advancements exemplifies how FACIT’s continuum of commercialization programs can strategically capitalize on homegrown talent and innovations to spur promising start-ups to grow roots in Ontario and bring cancer solutions to benefit patients sooner.
Read More from Idea to Investment Podcast: How FACIT’s support propels early cancer innovations
Pitch Your Cancer Innovation at Falcons’ Fortunes 2025
December 12, 2024 – Call for entrepreneurs and scientists to pitch your Ontario-made cancer innovation for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community. Apply by January 17, 2025.
Read More from Pitch Your Cancer Innovation at Falcons’ Fortunes 2025
Cutting-edge radiosurgery tech for brain tumours wins 2024 Falcons’ Fortunes
May 6, 2024 – At the sold-out Falcons’ Fortunes pitch competition hosted by FACIT, Dr. Hatim Fakir delivered the winning pitch as selected by the panel of judges for the $100,000 Ernsting Entrepreneurship Award. Developed at London Health Sciences Centre, Dr. Fakir’s RadioSphere is a patient-centred technology to revolutionize existing gamma knife radiotherapy procedures by providing the most precise tumour localization capabilities.
Read More from Cutting-edge radiosurgery tech for brain tumours wins 2024 Falcons’ Fortunes
Registration is now open for the 2024 Falcons’ Fortunes Pitch Finals – LIVE!
March 12, 2024 – You are invited to attend Falcons’ Fortunes, FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research and innovation communities. Now in its 11th year, the Falcons’ Fortunes event features six Ontario rising stars pitching their breakthrough cancer innovation as they compete for the $100,000 Ernsting Entrepreneurship Award.
Read More from Registration is now open for the 2024 Falcons’ Fortunes Pitch Finals – LIVE!
Falcons’ Fortunes 2024 – Pitch Your Cancer Innovation
January 31, 2024 – Apply Now! FACIT invites entrepreneurs and scientists to pitch their Ontario-made cancer innovation to a panel of judges and in front of a live audience for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community to drive a culture of commercialization where Ontario-based cancer research discoveries becomes Ontario-made solutions to benefit patients worldwide.
Read More from Falcons’ Fortunes 2024 – Pitch Your Cancer Innovation
Looking ahead to 2024
January 9, 2024 – The FACIT team is delighted to welcome the new year! For 2024, we maintain our focus on commercializing cancer research and attracting high tech jobs to Ontario. We look forward to working together with our stakeholders and partners to create good-paying jobs, accelerate commercialization and encourage the adoption of Ontario’s innovations to improve health care and grow the economy.
Happy Holidays from FACIT
December 7, 2023 – Season’s Greetings!
From the Ontario life science ecosystem, your friends at FACIT wish you and your family a safe and relaxing holiday season. We look forward to working with you in the new year.
FACIT applauds quizartinib approval: a success for leukemia patients and Canadian cancer research translation
July 24, 2023 – The U.S. FDA announced the approval of quizartinib, an important new therapy for patients with leukemia. This global effort to impact patients in need is to be celebrated while recognizing the contributions from across the Canadian health R&D ecosystem to reach this significant milestone that will now make a difference for patients.